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Abstract
Background
Carboxyl-ester lipase (CEL) contributes to fatty acid ethyl ester metabolism, which is impli-
cated in alcoholic pancreatitis. The CEL gene harbours a variable number of tandem repeats
(VNTR) region in exon 11. Variation in this VNTR has been linked to monogenic pancreatic
disease, while conflicting results were reported for chronic pancreatitis (CP). Here, we aimed
to investigate a potential association of CEL VNTR lengths with alcoholic CP.
Methods
Overall, 395 alcoholic CP patients, 218 patients with alcoholic liver cirrhosis (ALC) serving
as controls with a comparable amount of alcohol consumed, and 327 healthy controls from
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Germany and the United Kingdom (UK) were analysed by determination of fragment
lengths by capillary electrophoresis. Allele frequencies and genotypes of different VNTR
categories were compared between the groups.
Results
Twelve repeats were overrepresented in UK ACP patients (P = 0.04) compared to controls,
whereas twelve repeats were enriched in German ALC compared to alcoholic CP patients
(P = 0.03). Frequencies of CEL VNTR lengths of 14 and 15 repeats differed between Ger-
man ALC patients and healthy controls (P = 0.03 and 0.008, respectively). However, in the
genotype and pooled analysis of VNTR lengths no statistical significant association was
depicted. Additionally, the 16–16 genotype as well as 16 repeats were more frequent in UK
ALC than in alcoholic CP patients (P = 0.034 and 0.02, respectively). In all other calcula-
tions, including pooled German and UK data, allele frequencies and genotype distributions
did not differ significantly between patients and controls or between alcoholic CP and ALC.
Conclusions
We did not obtain evidence that CEL VNTR lengths are associated with alcoholic CP. How-
ever, our results suggest that CEL VNTR lengths might associate with ALC, a finding that
needs to be clarified in larger cohorts.
Introduction
Chronic pancreatitis (CP) is a recurring and painful inflammatory disease leading to exocrine
and endocrine insufficiency in many patients [1,2]. In the industrializedworld, alcohol abuse is
the predominant cause whereas smoking seems to be an independent risk factor. In non-alco-
holic CP, several genetic associations have recently been described.While variants in PRSS1
(cationic trypsinogen),CFTR (cystic fibrosis transmembrane conductance regulator), SPINK1
(serine protease, kazal type 1), CTRC (chymotrypsinogenC), CPA1 (carboxypeptidaseA1) and
the CLDN2-MORC4 locus have been identified to increase risk of CP development, a rare vari-
ant in PRSS2 (anionic trypsinogen) and a common variant in the PRSS1-PRSS2 locus are pro-
tective [3–10].
In alcoholic CP, genetic associations have been described for the variants p.N34S in
SPINK1, p.R254W in CTRC, and common variants of the PRSS1-PRSS2 and CLDN2-MORC4
locus [6,8,11]. This is an interesting finding because only five percent of patients with alcohol
abuse develop alcoholic CP, indicating that genetic or other factors contribute to disease devel-
opment. As such, further genetic associations with alcoholic CP might be identified by hypoth-
esis-driven as well as hypothesis-free approaches.
Carboxyl-ester lipase (CEL) is secreted into the pancreatic juice and contributes to the
hydrolysis of dietary lipids in the duodenum [12,13]. Pancreatitis is caused by intracellular cal-
cium overload, which can be induced by the presence of fatty acids and fatty acid ethyl esters
(FAEEs) within the pancreas [14]. FAEEs are a product of the non-oxidative metabolism of
ethanol and fatty acids and CEL is involved in this metabolic pathway [15–17].
A hybrid allele comprising parts of CEL and the neighbouringCEL pseudogene (CELP) con-
fers disease risk in non-alcoholic and alcoholic CP [18]. A variable number of tandem repeats
(VNTR), consisting of nearly identical 33-base pair segments, is located in CEL exon 11. This
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VNTR encodes a repetition of 11 amino acids located in the C-terminal part of the protein
[19–21]. Variations within this region have been linked to CEL-MODY, an autosomal domi-
nantly inherited disease characterized by monogenic diabetes and pancreatic exocrine dysfunc-
tion [19]. The most common CEL allele in the general population contains a VNTR of 16
segments, but VNTR lengths can vary between 3 and 23 repeats [19–23]. The definition of long
and short VNTR repeats, however, remains ambiguous in the literature and may contribute to
differing results when patients are analysed.
A Japanese study described an association of longer CELVNTR repeats (designated as the L
allele) with alcoholic CP, whereas no association was found in non-alcoholic CP patients and
in patients with alcohol abuse and no signs of CP [24]. Notably, the distribution of absolute
repeat numbers was not stated in that study. Moreover, this result was challenged by a recent
investigation of European CP patients, in that no statistically significant association between
CELVNTR lengths in alcoholic and non-alcoholic CP patients was identified [25]. To clarify
the role of the CELVNTR in alcoholic CP, we have here investigated alcoholic CP patients as
well as patients with alcoholic liver cirrhosis (ALC) and healthy controls from Germany and
the United Kingdom.We employed an established screeningmethod that accurately identifies
the length of the CELVNTR [25].
Materials and Methods
Study Subjects
The medical ethical review committee of the University Leipzig (Ethic committee of the medi-
cal faculty of the University Leipzig, Germany; http://home.uni-leipzig.de/ethik/index.htm;
Approval: 376-11-12122011) and the Multicentre Research Ethics Committees for Liverpool
(Approval 10/WN003/46 extended as 16/WA/0057 fromWales Research Ethics Committee 4,
United Kingdom, UK; Approval 11/NW/0347 and 09/H1010/75 fromNorth West Haydock
Research Ethics Committee 5, UK) approved the study protocol and all patients gave written
informed consent. Diagnosis of CP was based on two or more of the following findings: pres-
ence of a typical history of recurrent pancreatitis or recurrent abdominal pain typical for CP,
pancreatic calcifications and/or pancreatic ductal irregularities revealed by endoscopic retro-
grade pancreatography or by magnetic resonance imaging of the pancreas and/or pathological
sonographic findings. Alcoholic CP was defined in patients who had consumedmore than 80
g/d alcohol for at least two years in men and more than 60 g/d for women.
ALC was diagnosed according to results of liver biopsy (fibrosis stage 4) or due to unequivo-
cal clinical and laboratory findings in men who consumedmore than 80 g/d and in women
who consumedmore than 60 g/d for at least 10 years. Such findings were abnormal amino-
transferase level, gamma glutamyl transpeptidase level, coagulation tests, serum albumin con-
centration and platelet count, and/or complications related to liver cirrhosis including
esophageal varices, ascites, hepatic encephalopathy and typical liver morphology in sonogra-
phy or computed tomography. Other etiologies of liver cirrhosis were excluded by standard
laboratory tests.
In total, we enrolled 293 German alcoholic CP patients (87.7%males, age range 18–73
years, median 43 years), 127 German ALC patients (77.2%males, age range 32–78 years,
median 55 years), and 236 healthy German controls (50.9%males, age range 60–70 years,
median 63 years). No samples overlapped with those formerly reported in [25]. From the UK
in total 102 alcoholic CP patients (84%males, age range 20–72 years, median 43 years), 91
ALC patients (66%males, age range 34–80 years, median 57 years), and 91 healthy controls
(40%males, age range 35–62 years, median 58 years) were enrolled.
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Genotyping
Genomic DNA was extracted from peripheral blood leukocytes according to a standard proto-
col (QIAmp DNA BloodMini kit (Qiagen Cat No./ID 51106) or MagNA Pure isolation kit
(Roche Cat# 03730964001)). For analysis of CELVNTR lengths, polymerase chain reaction
(PCR) followed by DNA fragment analysis was performed as described in [25]. Briefly, PCR
was carried out using a forward primer binding upstream and partly into the first repeat of the
VNTR region, and a NED-labelled reverse primer binding downstream of the VNTR, resulting
in an amplified product covering the complete VNTR. The PCR products were diluted and
fragment analysis performed on an ABI 3100 capillary sequencer (Applied Biosystems). In
addition to a DNA size standard, a set of predetermined samples was used for calibration of
VNTR lengths. In the resulting spectra, the size (base pairs) of the NED-labelledDNA frag-
ments determined the total number of the CELVNTR repeats.
Statistics
The significance of the differences betweenVNTR frequencies was tested in affected individu-
als and controls by two-tailed Fisher's Exact or Pearson’s Chi-square test and P-values calcu-
lated using the Simple Interactive Statistical Analysis webpage (www.quantitativeskills.com/
sisa/index.htm).P-values<0.05 were considered statistically significant.
Results
CELVNTR lengths ranged from 7 to 23 repeats in the overall study population. In each of the
three cohorts, the most frequent allele contained 16 repeats (Germany/UK: alcoholic CP,
62.4%/55.6%; ALC, 58.4%/67.0%; controls, 59.7%/57.6%). The distribution of VNTR lengths in
healthy controls was comparable to that of previous studies [24, 25] and all cohorts were within
Hardy-Weinberg equilibrium.
During fragment analysis, some samples (Germany/UK: alcoholic CP, n = 7/3; ALC, n = 3/
3; healthy controls, n = 5/2) exhibited three NED-labelled peaks instead of the expected one or
two peaks [23]. The reason is that some individuals harbour a duplication variant of CEL,
implying that they carry an extra copy of the VNTR region [18, 23]. We have included the sub-
jects with three VNTR lengths in our analyses. Thus, when calculating the allele frequencies
the total number of alleles is slightly larger than twice the number of subjects.
Alcoholic CP vs Healthy Controls
When comparing VNTR allele frequencies between alcoholic CP patients and controls a
statistically significant difference was obtained for 12 repeats in the UK cohort, with overrepre-
sentation in patients (3.9%) versus controls (0.5%) (P = 0.04; odds ratio (OR) = 7.36; 95% con-
fidence interval (CI) = 0.91–53.39), that was not seen in the German cohorts (Tables 1 and 2).
Next, the VNTR lengths were pooled into three categories of short (S, 7–15 repeats), normal
(N, 16 repeats), and long (L, 17–23 repeats) alleles. In this pooled analysis, the distribution in
alcoholic CP patients and healthy controls did not differ significantly in either German or UK
cohorts (Tables 1 and 2, lower part). To address whether distinct genotypes (SS, SN, NN, NL,
LL, SL, or the presence of CEL duplication variants) contribute to alcoholic CP risk, genotype
frequencies were calculated in both groups. Again, there was no significant difference between
alcoholic CP patients and healthy controls (Tables 3 and 4).
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ALC vs Healthy Controls
Comparison of ALC patients and healthy controls revealed a statistically significant overrepre-
sentation of a VNTR length of 14 repeats in German patients (17.5%) vs. controls (11.7%)
(P = 0.03; OR = 1.60; 95% CI = 1.04–2.44). In contrast, an underrepresentation of 15 repeats
Table 1. Distribution of CEL VNTR lengths for alcoholic chronic pancreatitis (ACP) patients and controls from Germany.
Length frequency
ACP Controls P-valuea Odds ratio 95% CI
(n = 293) (n = 236)
Number of VNTR repeats 10 0.002 (1) 0.004 (2) 0.59 0.40 0.04–4.45
11 0.010 (6) 0.010 (5) 1.00 0.96 0.29–3.18
12 0.002 (1) 0.010 (5) 0.09 0.16 0.02–1.41
13 0.054 (32) 0.042 (20) 0.39 1.30 0.74–2.31
14 0.133 (79) 0.117 (56) 0.44* 1.16 0.80–1.67
15 0.138 (82) 0.170 (81) 0.15* 0.79 0.56–1.10
16 0.624 (370) 0.597 (285) 0.38* 1.12 0.87–1.43
17 0.030 (18) 0.046 (22) 0.20 0.65 0.34–1.22
18 0.003 (2) 0.002 (1) 1.00 1.61 0.15–17.82
21 0.002 (1) - - - -
23 0.002 (1) - - - -
Sum 1.000 (593) 1.000 (477) - - -
Pooled VNTR lengths Short (<16) 0.339 (201) 0.352 (168) 0.65* 0.94 0.73–1.22
Normal (16) 0.624 (370) 0.597 (285) 0.38* 1.12 0.87–1.43
Long (>16) 0.037 (22) 0.048 (23) 0.44 0.76 0.42–1.38
Sum 1.000 (593) 1.000 (477) - - -
a P-value calculated by two-tailed Fisher‘s exact test or Pearson’s Chi-square test (*) with one degree of freedom
doi:10.1371/journal.pone.0165567.t001
Table 2. Distribution of CEL VNTR lengths for alcoholic chronic pancreatitis (ACP) patients and controls from the United Kingdom.
Length frequency
ACP Controls P-valuea Odds ratio 95% CI
(n = 102) (n = 91)
Number of VNTR repeats 7 0.001 (2) - - - -
11 0.005 (1) - - - -
12 0.039 (8) 0.005 (1) 0.04 7.36 0.91–59.39
13 0.058 (12) 0.076 (14) 0.54 0.75 0.34–1.66
14 0.140 (29) 0.158 (29) 0.67 0.87 0.50–1.52
15 0.135 (28) 0.147 (27) 0.77 0.91 0.51–1.61
16 0.556 (115) 0.576 (106) 0.68* 0.92 0.62–1.37
17 0.048 (10) 0.038 (7) 0.81 1.28 0.48–3.44
18 0.001 (2) - - - -
Sum 1.000 (207) 1.000 (184) - - -
Pooled VNTR lengths Short (<16) 0.386 (80) 0.386 (71) 0.99* 1.00 0.67–1.51
Normal (16) 0.556 (115) 0.576 (106) 0.68 0.92 0.62–1.37
Long (>16) 0.058 (12) 0.038 (7) 0.48 1.56 0.60–4.04
Sum 1.000 (207) 1.000 (184) - - -
a P-value calculated by two-tailed Fisher‘s exact test or Pearson’s Chi-square test (*) with one degree of freedom
doi:10.1371/journal.pone.0165567.t002
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was found in German patients (9.7%) compared with controls (17.0%) (P = 0.008; OR = 0.53;
95% CI = 0.33–0.85) (Table 5). In the UK cohorts, VNTR length of 16 repeats was enriched in
ALC patients (67.0%) vs. controls (57.6%), but the difference did not quite reach statistical sig-
nificance (P = 0.06; OR = 1.50; 95% CI = 0.98–2.29). Calculations of pooledVNTR lengths and
genotype distribution in cohorts from both countries did not show differences between the
groups (Tables 5–8).
Alcoholic CP vs ALC
To examine a potential influence of alcohol consumption, alcoholic CP and ALC patients were
compared. Here, in the German cohorts, the VNTR lengths differed for 12 repeats (0.2% in
alcoholic CP vs. 1.6% in ALC patients; P = 0.03; OR = 0.11; 95% CI = 0.01–0.96) (Table 9).
Analyses of the pooledVNTR lengths and genotypes in the German cohorts did not identify
any associations. In the UK cohorts, VNTR lengths differed significantly for 16 repeats between
alcoholic CP (55.6%) and ALC patients (67.0) (P = 0.02; OR = 0.62; 95% CI = 0.41–0.93)
Table 3. Genotype distribution of CEL VNTR lengths for alcoholic chronic pancreatitis (ACP) patients and controls from Germany.
Genotypes of pooled lengthsa Frequency
ACP Controls P-valueb Odds ratio 95% CI
(n = 293) (n = 236)
SS 0.096 (28) 0.123 (29) 0.33 0.75 0.44–1.31
SN 0.423 (124) 0.403 (95) 0.63* 1.09 0.77–1.54
NN 0.392 (115) 0.364 (86) 0.51* 1.13 0.79–1.61
NL 0.038 (11) 0.055 (13) 0.40 0.67 0.29–1.52
LL - - - - -
SL 0.027 (8) 0.034(8) 0.80 0.80 0.30–2.17
Duplication allelesc 0.024 (7) 0.021 (5) 1.00 1.13 0.35–3.61
Sum 1.000 (293) 1.000 (236) - - -
a Short (S), 4–15 repeats; Normal (N), 16 repeats; Long (L), 17–23 repeats
b P-value calculated by two-tailed Fisher‘s exact test or Pearson’s Chi-square test (*) with one degree of freedom
c Genotypes of duplication alleles are listed in Table 13
doi:10.1371/journal.pone.0165567.t003
Table 4. Genotype distribution of CEL VNTR lengths for alcoholic chronic pancreatitis (ACP) patients and controls from the United Kingdom.
Genotypes of pooled lengthsa Frequency
ACP Controls P-valueb Odds ratio 95% CI
(n = 102) (n = 91)
SS 0.176 (18) 0.121 (11) 0.32 1.56 0.69–3.50
SN 0.363 (37) 0.450 (41) 0.22* 0.69 0.39–1.24
NN 0.324 (33) 0.330 (30) 1.00 0.97 0.53–1.78
NL 0.088 (9) 0.033 (3) 0.14 2.84 0.74–10.83
LL - - - - -
SL 0.020 (2) 0.044 (4) 0.42 0.44 0.08–2.43
Duplication allelesc 0.030 (3) 0.022 (2) 1.00 1.35 0.22–8.26
Sum 1.000 (102) 1.000 (91) - - -
a Short (S), 4–15 repeats; Normal (N), 16 repeats; Long (L), 17–23 repeats
b P-value calculated by two-tailed Fisher‘s exact test or Pearson’s Chi-square test (*) with one degree of freedom
c Genotypes of duplication alleles are listed in Table 14
doi:10.1371/journal.pone.0165567.t004
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(Tables 9–11). Genotype data also revealed an overrepresentation of the NN genotype in ALC
patients (47.3%) compared to alcoholic CP patients (32.4%) (P = 0.034; OR = 0.53; 95%
CI = 0.30–0.96) (Table 12).
Discussion
Taken together, this study of patients with alcoholic CP or ALC and healthy controls from two
countries has identified no evidence that CELVNTR lengths are associated with alcoholic CP.
Table 5. Distribution of CEL VNTR lengths for alcoholic liver cirrhosis (ALC) patients and controls from Germany.
Length frequency
ALC Controls P-valuea Odds ratio 95% CI
(n = 127) (n = 236)
Number of VNTR repeats 9 0.004 (1) - - - -
10 - 0.004 (2) - - -
11 0.012 (3) 0.010 (5) 1.00 1.12 0.26–4.70
12 0.016 (4) 0.010 (5) 0.73 1.50 0.40–5.61
13 0.066 (17) 0.042 (20) 0.16 1.62 0.83–3.15
14 0.175 (45) 0.117 (56) 0.03* 1.60 1.04–2.44
15 0.097 (25) 0.170 (81) 0.008 0.53 0.33–0.85
16 0.584 (150) 0.597 (285) 0.72* 0.94 0.69–1.29
17 0.043 (11) 0.046 (22) 1.00 0.92 0.44–1.94
18 0.004 (1) 0.002 (1) 1.00 1.86 0.12–29.85
Sum 1.000 (257) 1.000 (477) - - -
Pooled VNTR lengths Short (<16) 0.370 (95) 0.352 (168) 0.64* 1.08 0.79–1.48
Normal (16) 0.584 (150) 0.597 (285) 0.72* 0.94 0.69–1.29
Long (>16) 0.047 (12) 0.048 (23) 1.00 0.97 0.47–1.98
Sum 1.000 (257) 1.000 (477) - - -
a P-value calculated by two-tailed Fisher‘s exact test or Pearson’s Chi-square test (*) with one degree of freedom
doi:10.1371/journal.pone.0165567.t005
Table 6. Distribution of CEL VNTR lengths for alcoholic liver cirrhosis (ALC) patients and controls from the United Kingdom.
Length frequency
ALC Controls P-valuea Odds ratio 95% CI
(n = 91) (n = 91)
Number of VNTR 10 0.005 (1) - - - -
12 0.011 (2) 0.005 (1) 1.00 2.00 0.18–22.25
repeats 13 0.043 (8) 0.076 (14) 0.20 0.55 0.23–1.34
14 0.103 (19) 0.158 (29) 0.12 0.61 0.33–1.14
15 0.151 (28) 0.147 (27) 1.00 1.04 0.59–1.84
16 0.670 (124) 0.576 (106) 0.06* 1.50 0.98–2.29
17 0.016 (3) 0.038 (7) 0.22 0.42 0.11–1.64
Sum 1.000 (185) 1.000 (184) - - -
Pooled VNTR lengths Short (<16) 0.314 (58) 0.386 (71) 0.15* 0.73 0.47–1.12
Normal (16) 0.670 (124) 0.576 (106) 0.06* 1.50 0.98–2.29
Long (>16) 0.047 (3) 0.038 (7) 0.22 0.42 0.11–1.64
Sum 1.000 (185) 1.000 (184) - - -
a P-value calculated by two-tailed Fisher‘s exact test or Pearson’s Chi-square test (*) with one degree of freedom
doi:10.1371/journal.pone.0165567.t006
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This is in contrast to the previous Japanese study, which reported significant underrepresenta-
tion of the NN and overrepresentation of the NL genotype in alcoholic CP patients [24]. Of
note, the method applied to analyse the number of repeats was different from ours and allele
frequencies of exact VNTR lengths were not listed. Thus, we assumed that the 16-repeat allele
in the present analysis corresponds to theN-allele, less than 16 repeats to the S-allele, and more
than 16 repeats to the L-allele of the Japanese study [24]. If so, our results do not confirm the
observationmade in the Japanese population, but are more in line with the recent European
report [25].
Explanations for this discrepancymight be methodological in that alleles have been charac-
terised differently. In addition, there could be differences in alcohol consumption between Jap-
anese and European populations, since the Japanese VNTR study did not include the quantity
of alcohol consumed in the definition of alcoholic CP. Furthermore, a proportion of the Japa-
nese alcoholic controls may have had ALC or alcoholic CP. This is due to the fact, that these
individuals had documented attacks of acute pancreatitis, but a normal pancreatogram on
Table 7. Genotype distribution of CEL VNTR lengths for alcoholic liver cirrhosis (ALC) patients and controls from Germany.
Genotypes of pooled lengthsa Frequency
ALC Controls P-valueb Odds ratio 95% CI
(n = 127) (n = 236)
SS 0.134 (17) 0.123 (29) 0.74 1.10 0.58–2.10
SN 0.425 (54) 0.403 (95) 0.68* 1.10 0.71–1.70
NN 0.354 (45) 0.364 (86) 0.85* 0.96 0.61–1.50
NL 0.047 (6) 0.055 (13) 0.81 0.85 0.32–2.30
LL 0.008 (1) - - - -
SL 0.008 (1) 0.034 (8) 0.17 0.23 0.03–1.83
Duplication allelesc 0.024 (3) 0.021 (5) 1.00 1.12 0.26–4.76
Sum 1.000 (127) 1.000 (236) - - -
a Short (S), 4–15 repeats; Normal (N), 16 repeats; Long (L), 17–23 repeats
b P-value calculated by two-tailed Fisher‘s exact test or Pearson’s Chi-square test (*) with one degree of freedom
c Genotypes of duplication alleles are listed in Table 13
doi:10.1371/journal.pone.0165567.t007
Table 8. Genotype distribution of CEL VNTR lengths for alcoholic liver cirrhosis (ALC) patients and controls from the United Kingdom.
Genotypes of pooled lengthsa Frequency
ALC Controls P-valueb Odds ratio 95% CI
(n = 91) (n = 91)
SS 0.088 (8) 0.121 (11) 0.48 0.70 0.27–1.83
SN 0.385 (35) 0.450 (41) 0.37* 0.76 0.42–1.38
NN 0.473 (43) 0.330 (30) 0.07 1.82 1.00–3.32
NL - 0.033 (3) - - -
LL - - - - -
SL 0.022 (2) 0.044 (4) 0.68 0.49 0.09–2.74
Duplication allelesc 0.033 (3) 0.022 (2) 1.00 1.52 0.25–9.30
Sum 1.000 (91) 1.000 (91) - - -
a Short (S), 4–15 repeats; Normal (N), 16 repeats; Long (L), 17–23 repeats
b P-value calculated by two-tailed Fisher‘s exact test or Pearson’s Chi-square test (*) with one degree of freedom
c Genotypes of duplication alleles are listed in Table 14
doi:10.1371/journal.pone.0165567.t008
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endoscopic retrograde cholangiopancreaticography (ERCP), which makes alcoholic CP
unlikely, but does not rule this out [26]. Moreover, there were no documented investigations to
Table 9. Distribution of CEL VNTR lengths for alcoholic chronic pancreatitis (ACP) and alcoholic liver cirrhosis (ALC) patients from Germany.
Length frequency
ACP ALC P-valuea Odds ratio 95% CI
(n = 293) (n = 127)
Number of VNTR repeats 9 - 0.004 (1) - - -
10 0.002 (1) - - - -
11 0.010 (6) 0.012 (3) 1.00 0.86 0.22–3.49
12 0.002 (1) 0.016 (4) 0.03 0.11 0.01–0.96
13 0.054 (32) 0.066 (17) 0.52 0.81 0.44–1.48
14 0.133 (79) 0.175 (45) 0.11* 0.72 0.49–1.08
15 0.138 (82) 0.097 (25) 0.11 1.49 0.93–2.39
16 0.624 (370) 0.584 (150) 0.27* 1.18 0.88–1.60
17 0.030 (18) 0.043 (11) 0.41 0.70 0.33–1.50
18 0.003 (2) 0.004 (1) 1.00 0.87 0.08–9.60
21 0.002 (1) - - - -
23 0.002 (1) - - - -
Sum 1.000 (593) 1.000 (257) - - -
Pooled VNTR lengths Short (<16) 0.339 (201) 0.370 (95) 0.39* 0.87 0.64–1.19
Normal (16) 0.624 (370) 0.584 (150) 0.27* 1.18 0.88–1.60
Long (>16) 0.037 (22) 0.047 (12) 0.57 0.79 0.38–1.62
Sum 1.000 (593) 1.000 (257) - - -
a P-value calculated by two-tailed Fisher‘s exact test or Pearson’s Chi-square test (*) with one degree of freedom
doi:10.1371/journal.pone.0165567.t009
Table 10. Distribution of CEL VNTR lengths for alcoholic chronic pancreatitis (ACP) and alcoholic liver cirrhosis (ALC) patients from the United
Kingdom.
Length frequency
ACP ALC P-valuea Odds ratio 95% CI
(n = 102) (n = 91)
Number of VNTR repeats 7 0.001 (2) - - - -
10 - 0.005 (1) - - -
11 0.005 (1) - - - -
12 0.039 (8) 0.011 (2) 0.11 3.68 0.77–17.55
13 0.058 (12) 0.043 (8) 0.65 1.36 0.54–3.48
14 0.140 (29) 0.103 (19) 0.28 1.42 0.77–2.64
15 0.135 (28) 0.151 (28) 0.67 0.88 0.50–1.54
16 0.556 (115) 0.670 (124) 0.02* 0.62 0.41–0.93
17 0.048 (10) 0.016 (3) 0.09 3.08 0.83–11.37
18 0.001 (2) - - - -
Sum 1.000 (207) 1.000 (185) - - -
Pooled VNTR lengths Short (<16) 0.386 (80) 0.314 (58) 0.13* 1.38 0.91–2.10
Normal (16) 0.556 (115) 0.670 (124) 0.02* 0.62 0.41–0.93
Long (>16) 0.058 (12) 0.016 (3) 0.04 3.73 1.04–13.44
Sum 1.000 (207) 1.000 (185) - - -
a P-value calculated by two-tailed Fisher‘s exact test or Pearson’s Chi-square test (*) with one degree of freedom
doi:10.1371/journal.pone.0165567.t010
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rule out ALC. Otherwise, since the number of Japanese alcoholic CP patients was rather small
it is difficult to draw valid conclusions from the reported data and it would be helpful to see
replication in another Japanese cohort.
Alcoholic CP and ALC can be found concomitantly in patients, indicating that common
pathways for disease development might be involved. It has been reported that clinical alco-
holic CP and ALC occur concurrently in around 16–20% of alcoholic CP/ALC cases, but the
prevalencemay be higher at a histological level [27–29]. It is generally agreed, however, that
there is some unknown factor(s) that predispose individuals to one or the other disease process
[30, 31]. Nevertheless, the two groups can serve as controls for each other to adjust for the
influence of alcohol intake, since they share a similar amount of consumed alcohol. Therefore,
a joint analysis of alcoholic CP and ALC patients is valuable when attempting to identify
genetic risk factors underlying alcohol-related diseases.
Table 12. Genotype distribution of CEL VNTR lengths for alcoholic chronic pancreatitis (ACP) and alcoholic liver cirrhosis (ALC) patients from
the United Kingdom.
Genotypes of pooled lengthsa Frequency
ACP ALC P-valueb Odds ratio 95% CI
(n = 102) (n = 91)
SS 0.176 (18) 0.088 (8) 0.09 2.22 0.92–5.39
SN 0.363 (37) 0.385 (35) 0.75* 0.91 0.51–1.63
NN 0.324 (33) 0.473 (43) 0.034* 0.53 0.30–0.96
NL 0.088 (9) - - - -
LL - - - - -
SL 0.020 (2) 0.022 (2) 1.0 0.89 0.12–6.45
Duplication allelesc 0.030 (3) 0.033 (3) 1.0 0.89 0.18–4.52
Sum 1.000 (102) 1.000 (91) - - -
a Short (S), 4–15 repeats; Normal (N), 16 repeats; Long (L), 17–23 repeats
b P-value calculated by two-tailed Fisher‘s exact test or Pearsons Chi-square test (*) with one degree of freedom
c Genotypes of duplication alleles are listed in Table 14
doi:10.1371/journal.pone.0165567.t012
Table 11. Genotype distribution of CEL VNTR lengths for alcoholic chronic pancreatitis (ACP) and alcoholic liver cirrhosis (ALC) patients from
Germany.
Genotypes of pooled lengthsa Frequency
ACP ALC P-valueb Odds ratio 95% CI
(n = 293) (n = 127)
SS 0.096 (28) 0.134 (17) 0.30 0.68 0.36–1.30
SN 0.423 (124) 0.425 (54) 0.97* 0.99 0.65–1.51
NN 0.392 (115) 0.354 (45) 0.46* 1.18 0.76–1.82
NL 0.038 (11) 0.047 (6) 0.60 0.79 0.28–2.18
LL - 0.008 (1) - - -
SL 0.027 (8) 0.008 (1) 0.29 3.54 0.44–28.58
Duplication allelesc 0.024 (7) 0.024 (3) 1.00 1.01 0.26–3.98
Sum 1.000 (293) 1.000 (127) - - -
a Short (S), 4–15 repeats; Normal (N), 16 repeats; Long (L), 17–23 repeats
b P-value calculated by two-tailed Fisher‘s exact test or Pearson’s Chi-square test (*) with one degree of freedom
c Genotypes of duplication alleles are listed in Table 13
doi:10.1371/journal.pone.0165567.t011
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In our comparison of German ALC patients with healthy controls, 14 repeats were enriched
in patients while 15 repeats were underrepresented. Further, 12 repeats were enriched in Ger-
man ALC compared to alcoholic CP patients. Additionally, 16 repeats were overrepresented in
ALC patients from the UK in comparison to alcoholic CP patients and with borderline signifi-
cance in comparison to controls. As well the NN genotype was more frequent in ALC than in
alcoholic CP patients. Thus, these results indicate a possible association of CELVNTR lengths
with the disease pathogenesis of ALC, however, the definite repeat lengths cannot be defined in
this stage. A possible pathophysiological explanation for how CELVNTR length contributes to
ALC development might be the determination of plasma lipid levels, as CELVNTR length
seems to influence total and low density lipoprotein cholesterol levels [32]. This would be in
line with findings in a recent genome wide associations study that identified three risk loci for
ALC involved in lipid metabolic processes [33]. Further studies are warranted with larger ALC
cohorts to determine whether our findings can be attributed to a population bias from one or
more genes, which our data suggest is more likely, or to a specific high-risk allele.
Table 14. Genotypes of observed CEL duplication alleles from the United Kingdom.
Materials Number of VNTR repeats S/N/La
Alcoholic
chronic 14 15 16 SSN
pancreatitis 14 15 16 SSN
(n = 3) 15 16 18 SNL
Alcoholic liver 14 15 16 SSN
cirrhosis 14 15 16 SSN
(n = 3) 14 16 17 SNL
Controls 13 14 16 SSN
(n = 2) 14 15 16 SSN
a Short (S), 4–15 repeats; Normal (N), 16 repeats; Long (L), 17–23 repeats
doi:10.1371/journal.pone.0165567.t014
Table 13. Genotypes of observed CEL duplication alleles from Germany.
Materials Number of VNTR repeats S/N/La
Alcoholic 13 14 16 SSN
chronic 14 15 16 SSN
pancreatitis 14 15 16 SSN
(n = 7) 14 15 16 SSN
14 16 17 SNL
14 16 17 SNL
14 16 23 SNL
Alcoholic liver 14 15 16 SSN
cirrhosis 14 15 17 SSL
(n = 3) 15 16 17 SNL
Controls 11 15 16 SSN
(n = 5) 13 14 16 SSN
14 15 16 SSN
14 16 17 SNL
15 16 17 SNL
a Short (S), 4–15 repeats; Normal (N), 16 repeats; Long (L), 17–23 repeats
doi:10.1371/journal.pone.0165567.t013
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In this study we used blood donors as controls, which might bias the results since some con-
trols may suffer from alcoholic CP or ALC. Still, this potential confounder is surmised to be
negligible due to the low prevalence of alcoholic CP and ALC in the general population as well
as the strict screening protocols that blood donors have to undergo. In addition, allele frequen-
cies and genotype data in our control group are comparable to former reports, and as such
indicate that the selected control group is suitable for the conclusions drawn. Another limita-
tion of this study could be that our method cannot distinguish samples carrying an extra copy
of the CELVNTR (e.g. with 14-16-16 repeats) from those samples that are truly heterozygous
with regard to VNTR length (e.g. with 14–16 repeats). Consequently, we might have underesti-
mated the number of carriers with three copies of the VNTR. Nevertheless from our data
(Tables 13 and 14) it seems reasonable to propose that carriers with three copies are similarly
distributed in patients and controls. Moreover, a reanalysis of our data with samples containing
three VNTR lengths excluded did not alter the results (data not shown).
In conclusion, we present a comprehensive analysis of CELVNTR lengths in cohorts of
patients with alcoholic CP or ALC and healthy controls from Germany and the UK. In line
with the former European study [25], we did not identify any association betweenVNTR
lengths allele frequencies or genotypes and alcoholic CP. Further work needs to be undertaken
to determine how CEL variants may affect the development and progression of ALC.
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